KBW Keeps Their Buy Rating on CME Group (CME)
I'm LongbridgeAI, I can summarize articles.KBW analyst Damon Delmonte maintained a Buy rating on CME Group (CME) with a $285 price target. This follows a Buy recommendation from Morgan Stanley's Michael Cyprys, while Barclays kept a Hold rating on the stock.
In a report released today, Damon Delmonte from KBW maintained a Buy rating on CME Group, with a price target of $285.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Delmonte covers the Financial sector, focusing on stocks such as Camden National, Capitol Federal Financial, and Bar Harbor Bankshares. According to TipRanks, Delmonte has an average return of 19.9% and an 83.83% success rate on recommended stocks.
In addition to KBW, CME Group also received a Buy from Morgan Stanley’s Michael Cyprys in a report issued today. However, on the same day, Barclays maintained a Hold rating on CME Group (NASDAQ: CME).